Home・Elenco Azioni・Haemonetics Corp

Haemonetics Corp

Chiusa

SettoreSettore sanitario

90.84 0.63

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

89.32

Massimo

91.22

Metriche Chiave
By Trading Economics
Entrata	53M 33M
Vendite	-7M 339M
P/E Media del settore	42.456 57.002
EPS	1.14
Margine di Profitto	9.727
Dipendenti	3,009
EBITDA	70M 75M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+4.15% upside

Dividendi
By Acuity
Utili prossimi	5 nov 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-3.8M 3.9B
Apertura precedente	90.21
Chiusura precedente	90.84

Notizie sul Sentiment di mercato

By Acuity

95%

4 / 340 Classifica in Healthcare

Haemonetics Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

14 ago 2026, 19:51 UTC

Haemonetics Corp shares are higher today, supported by a positive trend in the Health Care Supplies sector and increased trading volume.

13 ago 2026, 19:51 UTC

Haemonetics shares are declining amid rising jobless claims and flat Producer Price Index data, breaking a recent trend of higher daily closes.

12 ago 2026, 20:01 UTC

Haemonetics Corp shares are higher today, supported by unusually high trading volume and a strong upward trajectory since Tuesday's close.

11 ago 2026, 20:06 UTC

Haemonetics Corp shares are higher today, maintaining a position near the upper end of their one-month range despite a minor pullback earlier in the session.

10 ago 2026, 19:46 UTC

Haemonetics Corp shares are declining amid broader market uncertainty following recent U.S. employment data, despite earlier gains during the session.

7 ago 2026, 22:01 UTC

News

Haemonetics shares are lower in after-market trading despite Citigroup raising its price target to $92 and maintaining a Neutral rating.

6 ago 2026, 21:01 UTC

Haemonetics Corp. shares are trading higher in after-market hours, remaining above the 20-day moving average and near the upper end of their one-month range.

5 ago 2026, 19:31 UTC

Haemonetics Corp shares are lower today, breaking a trend of higher closes. The stock is experiencing unusually high trading volume amid no specific news.

4 ago 2026, 21:01 UTC

Haemonetics Corp shares declined in after-market hours, despite broader market gains from positive U.S.-Iran negotiations and falling crude oil prices.

3 ago 2026, 19:56 UTC

Haemonetics Corp shares are higher, reflecting broader market gains amid positive momentum in major tech stocks and easing geopolitical tensions.

31 lug 2026, 20:04 UTC

Haemonetics Corp shares are higher, with no specific news identified. The broader market has also gained since Thursday's close, recovering from earlier losses.

30 lug 2026, 19:48 UTC

Haemonetics Corp. shares are lower today, continuing a decline since Wednesday. The stock remains above its 20-day moving average despite recent downward movement.

29 lug 2026, 21:21 UTC

Haemonetics Corp shares are lower in after-market trading, reflecting broader declines in the equity market and Health Care Supplies sector amid rising oil prices.

28 lug 2026, 21:01 UTC

Haemonetics Corp shares are lower in after-market hours, following a broader market decline amid a significant drop in the Nikkei 225 Index.

27 lug 2026, 22:51 UTC

Haemonetics Corp shares are higher in after-market trading, supported by falling crude oil prices and strong performance above the 20-day moving average.

24 lug 2026, 20:31 UTC

Haemonetics Corp shares are lower in after-market hours, continuing a decline from Friday's close. No specific news was identified to explain the movement.

23 lug 2026, 23:21 UTC

Haemonetics Corp shares are lower in after-market trading, continuing a decline that began after Thursday's close, reaching the midpoint of their one-month trading range.

22 lug 2026, 20:13 UTC

Shares of Haemonetics Corp are trading higher in after-market hours, positioned above its 20-day moving average amid broader market volatility and rising crude oil prices.

20 lug 2026, 18:46 UTC

Haemonetics Corp shares are higher today, continuing gains since Friday's close. The stock reached a session high earlier, though it has pulled back.

Confronto tra pari

Modifica del prezzo

Haemonetics Corp Previsione

Obiettivo di Prezzo

By TipRanks

4.15% in crescita

Previsioni per 12 mesi

Media 94.13 USD 4.15%

Alto 105 USD

Basso 84 USD

Basato su 9 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Haemonetics Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

9 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 9 che hanno fornito valutazioni azionarie a Haemonetics Corp - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

4 / 340 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Haemonetics Corp

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.